Does the media prefer MMSI or STAA?

In the previous week, STAAR Surgical had 2 more articles in the media than Merit Medical Systems. MarketBeat recorded 4 mentions for STAAR Surgical and 2 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.94 beat STAAR Surgical's score of 0.34 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ICUI or STAA?

In the previous week, STAAR Surgical had 1 more articles in the media than ICU Medical. MarketBeat recorded 4 mentions for STAAR Surgical and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.67 beat STAAR Surgical's score of 0.34 indicating that ICU Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor STAA or HAE?

In the previous week, STAAR Surgical had 3 more articles in the media than Haemonetics. MarketBeat recorded 4 mentions for STAAR Surgical and 1 mentions for Haemonetics. STAAR Surgical's average media sentiment score of 0.34 beat Haemonetics' score of -0.50 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Haemonetics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media refer more to XRAY or STAA?

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 6 mentions for DENTSPLY SIRONA and 4 mentions for STAAR Surgical. DENTSPLY SIRONA's average media sentiment score of 0.83 beat STAAR Surgical's score of 0.34 indicating that DENTSPLY SIRONA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is STAA or NEOG more profitable?

STAAR Surgical has a net margin of -7.24% compared to Neogen's net margin of -69.93%. STAAR Surgical's return on equity of 3.31% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets STAAR Surgical -7.24% 3.31% 2.55% Neogen -69.93% 2.35% 1.46%

STAAR Surgical (STAA) Competitors

$27.76 -0.21 (-0.75%)

Closing price 07/10/2026 04:00 PM Eastern

Extended Trading

$27.75 -0.01 (-0.05%)

As of 07/10/2026 07:22 PM Eastern

Compare

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

Should you buy STAAR Surgical stock or one of its competitors? MarketBeat compares STAAR Surgical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with STAAR Surgical include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), and Neogen (NEOG). These companies are all part of the "health care supplies" industry.

How does STAAR Surgical compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by company insiders. Comparatively, 39.9% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Merit Medical Systems has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market.

Merit Medical Systems presently has a consensus price target of $92.80, suggesting a potential upside of 26.36%. STAAR Surgical has a consensus price target of $27.81, suggesting a potential upside of 0.19%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, equities research analysts clearly believe Merit Medical Systems is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09

Merit Medical Systems has a net margin of 9.03% compared to STAAR Surgical's net margin of -7.24%. Merit Medical Systems' return on equity of 13.54% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
STAAR Surgical	-7.24%	3.31%	2.55%

In the previous week, STAAR Surgical had 2 more articles in the media than Merit Medical Systems. MarketBeat recorded 4 mentions for STAAR Surgical and 2 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.94 beat STAAR Surgical's score of 0.34 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Merit Medical Systems has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	2.89	$128.49M	$2.31	31.79
STAAR Surgical	$239.44M	5.77	-$80.45M	-$0.43	N/A

Summary

Merit Medical Systems beats STAAR Surgical on 12 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

ICU Medical presently has a consensus target price of $168.40, suggesting a potential upside of 9.05%. STAAR Surgical has a consensus target price of $27.81, suggesting a potential upside of 0.19%. Given ICU Medical's stronger consensus rating and higher possible upside, research analysts plainly believe ICU Medical is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	3 Strong Buy rating(s)	3.00
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 39.9% of STAAR Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

ICU Medical has a net margin of 2.15% compared to STAAR Surgical's net margin of -7.24%. ICU Medical's return on equity of 7.50% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	2.15%	7.50%	3.91%
STAAR Surgical	-7.24%	3.31%	2.55%

In the previous week, STAAR Surgical had 1 more articles in the media than ICU Medical. MarketBeat recorded 4 mentions for STAAR Surgical and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.67 beat STAAR Surgical's score of 0.34 indicating that ICU Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

ICU Medical has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market.

ICU Medical has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	1.73	$730K	$1.85	83.47
STAAR Surgical	$239.44M	5.77	-$80.45M	-$0.43	N/A

Summary

ICU Medical beats STAAR Surgical on 12 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to Haemonetics?

STAAR Surgical (NASDAQ:STAA) and Haemonetics (NYSE:HAE) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

STAAR Surgical currently has a consensus price target of $27.81, indicating a potential upside of 0.19%. Haemonetics has a consensus price target of $78.33, indicating a potential upside of 3.00%. Given Haemonetics' stronger consensus rating and higher possible upside, analysts clearly believe Haemonetics is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by insiders. Comparatively, 2.1% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

STAAR Surgical has a beta of 1.23, suggesting that its share price is 23% more volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

Haemonetics has a net margin of 7.29% compared to STAAR Surgical's net margin of -7.24%. Haemonetics' return on equity of 27.30% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Haemonetics	7.29%	27.30%	9.59%

In the previous week, STAAR Surgical had 3 more articles in the media than Haemonetics. MarketBeat recorded 4 mentions for STAAR Surgical and 1 mentions for Haemonetics. STAAR Surgical's average media sentiment score of 0.34 beat Haemonetics' score of -0.50 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Haemonetics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Haemonetics has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.77	-$80.45M	-$0.43	N/A
Haemonetics	$1.33B	2.59	$97.31M	$2.02	37.65

Summary

Haemonetics beats STAAR Surgical on 12 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

DENTSPLY SIRONA has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market.

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 6 mentions for DENTSPLY SIRONA and 4 mentions for STAAR Surgical. DENTSPLY SIRONA's average media sentiment score of 0.83 beat STAAR Surgical's score of 0.34 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

STAAR Surgical has a net margin of -7.24% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
STAAR Surgical	-7.24%	3.31%	2.55%

DENTSPLY SIRONA presently has a consensus price target of $13.42, suggesting a potential upside of 9.43%. STAAR Surgical has a consensus price target of $27.81, suggesting a potential upside of 0.19%. Given DENTSPLY SIRONA's higher possible upside, research analysts plainly believe DENTSPLY SIRONA is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 39.9% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

STAAR Surgical has lower revenue, but higher earnings than DENTSPLY SIRONA. STAAR Surgical is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.67	-$598M	-$3.15	N/A
STAAR Surgical	$239.44M	5.77	-$80.45M	-$0.43	N/A

Summary

STAAR Surgical beats DENTSPLY SIRONA on 8 of the 15 factors compared between the two stocks.

How does STAAR Surgical compare to Neogen?

STAAR Surgical (NASDAQ:STAA) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

STAAR Surgical presently has a consensus target price of $27.81, suggesting a potential upside of 0.19%. Neogen has a consensus target price of $10.67, suggesting a potential upside of 10.88%. Given Neogen's stronger consensus rating and higher possible upside, analysts clearly believe Neogen is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	2 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.09
Neogen	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, STAAR Surgical had 3 more articles in the media than Neogen. MarketBeat recorded 4 mentions for STAAR Surgical and 1 mentions for Neogen. STAAR Surgical's average media sentiment score of 0.34 beat Neogen's score of 0.00 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Overall Sentiment
STAAR Surgical	Neutral
Neogen	Neutral

STAAR Surgical has a net margin of -7.24% compared to Neogen's net margin of -69.93%. STAAR Surgical's return on equity of 3.31% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Neogen	-69.93%	2.35%	1.46%

STAAR Surgical has higher earnings, but lower revenue than Neogen. STAAR Surgical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.77	-$80.45M	-$0.43	N/A
Neogen	$894.66M	2.34	-$1.09B	-$2.80	N/A

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 39.9% of STAAR Surgical shares are held by company insiders. Comparatively, 0.6% of Neogen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

STAAR Surgical has a beta of 1.23, meaning that its stock price is 23% more volatile than the broader market. Comparatively, Neogen has a beta of 1.8, meaning that its stock price is 80% more volatile than the broader market.

Summary

STAAR Surgical beats Neogen on 10 of the 16 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STAA vs. The Competition

Export

Metric	STAAR Surgical	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.39B	$16.50B	$7.12B	$12.61B
Dividend Yield	N/A	1.33%	2.68%	7.83%
P/E Ratio	-64.56	19.15	27.22	24.56
Price / Sales	5.77	2.39	590.16	121.71
Price / Cash	N/A	14.23	49.34	60.04
Price / Book	4.01	3.37	10.90	6.39
Net Income	-$80.45M	$534.24M	$3.57B	$331.44M
7 Day Performance	-0.11%	0.39%	-0.25%	0.37%
1 Month Performance	-3.94%	3.09%	5.77%	2.17%
1 Year Performance	59.72%	0.62%	28.14%	20.90%

STAAR Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STAA STAAR Surgical	1.6733 of 5 stars	$27.76 -0.8%	$27.81 +0.2%	+55.9%	$1.39B	$239.44M	N/A	1,211	News Coverage
MMSI Merit Medical Systems	4.3276 of 5 stars	$71.45 +0.5%	$92.80 +29.9%	-22.8%	$4.24B	$1.52B	30.93	7,500	Positive News Analyst Forecast
ICUI ICU Medical	3.3285 of 5 stars	$159.43 +2.9%	$168.40 +5.6%	+12.5%	$3.87B	$2.23B	86.18	13,000
HAE Haemonetics	2.2549 of 5 stars	$75.03 -0.1%	$78.33 +4.4%	-2.9%	$3.41B	$1.33B	37.14	3,009	Negative News Analyst Forecast
XRAY DENTSPLY SIRONA	4.307 of 5 stars	$12.32 +5.8%	$13.55 +9.9%	-26.2%	$2.33B	$3.68B	N/A	14,000	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STAA) was last updated on 7/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STAAR Surgical (STAA) Competitors

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does STAAR Surgical compare to Merit Medical Systems?

Summary

How does STAAR Surgical compare to ICU Medical?

Summary

How does STAAR Surgical compare to Haemonetics?

Summary

How does STAAR Surgical compare to DENTSPLY SIRONA?

Summary

How does STAAR Surgical compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STAAR Surgical (STAA) Competitors

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does STAAR Surgical compare to Merit Medical Systems?

Do institutionals & insiders have more ownership in MMSI or STAA?

Which has more risk & volatility, MMSI or STAA?

Do analysts prefer MMSI or STAA?

Is MMSI or STAA more profitable?

Does the media prefer MMSI or STAA?

Which has higher valuation and earnings, MMSI or STAA?

Summary

How does STAAR Surgical compare to ICU Medical?

Do analysts prefer ICUI or STAA?

Do insiders & institutionals have more ownership in ICUI or STAA?

Is ICUI or STAA more profitable?

Does the media prefer ICUI or STAA?

Which has more risk and volatility, ICUI or STAA?

Which has preferable earnings & valuation, ICUI or STAA?

Summary

How does STAAR Surgical compare to Haemonetics?

Do analysts recommend STAA or HAE?

Do insiders and institutionals believe in STAA or HAE?

Which has more volatility & risk, STAA or HAE?

Is STAA or HAE more profitable?

Does the media favor STAA or HAE?

Which has higher earnings and valuation, STAA or HAE?

Summary

How does STAAR Surgical compare to DENTSPLY SIRONA?

Which has more volatility & risk, XRAY or STAA?

Does the media refer more to XRAY or STAA?

Is XRAY or STAA more profitable?

Do analysts rate XRAY or STAA?

Do institutionals and insiders hold more shares of XRAY or STAA?

Which has better earnings & valuation, XRAY or STAA?

Summary

How does STAAR Surgical compare to Neogen?

Do analysts rate STAA or NEOG?

Does the media favor STAA or NEOG?

Is STAA or NEOG more profitable?

Which has stronger earnings & valuation, STAA or NEOG?

Do insiders and institutionals have more ownership in STAA or NEOG?

Which has more volatility and risk, STAA or NEOG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools